Lingke Pharmaceuticals completes patient enrolment...
Category : Clinical Trial Update 16 July 2026Lingke Pharmaceutical (Zhejiang) Co., Ltd. (Lingke Pharmaceutical), a clinical-stage innovative drug...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
US FDA clears Atrium Therapeutics’ IND application...
Category : Clinical Trial Update 16 July 2026Atrium Therapeutics, Inc., a biopharmaceutical company dedicated to delivering RNA therapeutics to t...
Celea Therapeutics Doses First Patient in Global P...
Category : Clinical Trial Update 15 July 2026Celea Therapeutics has announced that the first patient has been dosed in its global Phase 3 SURPASS...
Skyhawk Therapeutics Expands Global Phase 2/3 Tria...
Category : Clinical Trial Update 15 July 2026Skyhawk Therapeutics has received additional regulatory approvals to expand its global Phase 2/3 FAL...
Rani Therapeutics and PegBio Partner to Develop Or...
Category : Licensing/Collaboration Deal 14 July 2026Companies Team Up to Expand Oral Biologic Therapy Development Rani Therapeutics Holdings, Inc. ha...
Latest Newsletter Post
-
US FDA clears Atrium Therapeutics’..
16 July 2026
-
Lingke Pharmaceuticals completes pa..
16 July 2026
-
Skyhawk Therapeutics Expands Global..
15 July 2026
-
Celea Therapeutics Doses First Pati..
15 July 2026
-
AlloSource Launches ReConnex Pre-Su..
14 July 2026
